Veja nosso trabalho apresentado
em congressos.

ACR 2026
Orlando, Florida

Anti-C1Q and Anti-DSDNA antibodies centrally assessed predict renal involvement in sle patients from the GLADEL 2.0 cohort.

Intravenous cyclophosphamide versus mycophenolate mofetil for induction therapy in incident lupus nephritis: data from a multi-ethnic, multinational Latin American cohort (GLADEL 2.0)

Pregnancy and obstetric outcomes in systemic lupus erythematosus: insights from the GLADEL 2.0 cohort

Nephritis and its response to therapy using the rail urine biomarkers in the GLADEL cohort
ACR 2026 / Pôsteres colaborativos da LupusNet

Organ Damage and Its Relationship with Disease Activity in Systemic Lupus Erythematosus: Insights from the Lupus Federated Data Network (LupusNet)

Age at Onset and Its Association With Damage Accrual in Systemic Lupus Erythematosus (SLE): Insights From 5 Registries in the Lupus Federated Data Network (LupusNet).

Disease Activity, Organ Damage, and Treatment Exposure in Systemic Lupus Erythematosus With Neuropsychiatric Involvement: Insights From the Lupus Federated Data Network (LupusNet)

Longitudinal Disease Activity, Damage Accrual, and Treatment Exposure in Systemic Lupus Erythematosus With Lupus Nephritis: Insights From the Lupus Federated Data Network (LupusNet)

Systemic Treatment Patterns in Systemic Lupus Erythematosus (SLE): Associations with Disease Severity and Organ-Specific Activity Across 5 Registries in the Lupus Federated Data Network (LupusNet)
PANLAR 2026
Panamá, PANAMÁ

Feasibility of extrarenal Systemic Lupus Erythematosus disease modification in GLADEL 2.0, a Latin American cohort

Incidence of venous thromboembolism, risks factors and impact on quality of life in patients with Systemic Lupus Erythematosus from a Latin American cohort

Intravenous cyclophosphamide versus mycophenolate mofetil for induction therapy in incident lupus nephritis: data from a multi¬ethnic, Multinational Latin American Cohort (GLADEL 2.0)

Systemic Lupus Erythematosus and statins in GLADEL 2.0: are cardiovascular risk prevention guidelines being followed?
15th European Lupus Meeting 2026
Lisboa, PORTUGAL

Systemic Lupus Erythematosus and statins in GLADEL 2.0: are cardiovascular risk prevention guidelines being followed?

Cluster analysis of socioeconomic and environmental determinants modifying activity, chronicity and clinical manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 cohort

Risk factors for pulmonary manifestations in GLADEL 2.0, a Systemic Lupus Erythematosus Latin American cohort
ACR 2025
Chicago, USA

Risk factors for pulmonary manifestations in GLADEL 2.0, a Systemic Lupus Erythematosus Latin American cohort

Effect of gender and follow-up time in damage accrual: Data from a Latin America lupus cohort

Cluster analysis of socioeconomic and environmental determinants Modifying activity, chronicity and clinical manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 cohort

Feasibility of extrarenal Systemic Lupus Erythematosus disease modification in GLADEL 2.0, a Latin American cohort

Systemic Lupus Erythematosus and statins in GLADEL 2.0: Are cardiovascular risk prevention guidelines being followed?

The renal activity index for lupus identifies and predicts complete renal remission or absence of kidney involvement in Systemic Lupus Erythematosus
EULAR 2025
Barcelona, España

The Renal Activity Index for Lupus Identifies and Predicts Complete Renal Remission or Absence of Kidney Involvement in Systemic Lupus Erythematosus.

Cross cultural validation of Work Productivity and Activity Impairment questionnaire in lupus patients from Latin America.

Effect of gender and follow-up time in damage accrual: data from a Latin America lupus cohort.
16th International Congress on SLE 2025
Toronto, Canada

Delay in diagnosis and treatment of patients with Systemic lupus erythematosus in latin america. A mixed methods study.
%20-%20eposter.jpg)
Living with systemic lupus erythematosus in 2024: latin american experience based on a patient survey.

Systematic review and network meta¬analysis of induction treatments for lupus nephritis

Validation of a score for the prediction of serious Infection in patients with systemic lupus erythematosus: Data from a latin american lupus cohort.
PANLAR 2025
CDMX, Mexico

Delay in diagnosis and treatment of patients with systemic lupus erythematosus in Latin America. A mixed methods study.

Frequency and associated factors of herpes zoster infection in systemic lupus erythematosus patients from Latin America.

Living with systemic lupus erythematosus in 2024: Latin American experience based on a patient survey.

Validation of a score for the prediction of serious infection in patients with systemic lupus erythematosus: Data from a Latin American lupus cohort.

Systematic review and network meta analysis of initial treatments for lupus nephritis.

Socioeconomic and environmental factors associated with clinical manifestations, activity, and chronicity of systemic lupus erythematosus: A multilevel study of the GLADEL cohort.

Delayed diagnosis in Systemic lupus erythematosus.
ACR 2024
Washington, D.C.


Delayed Diagnosis in Systemic Lupus Erythematosus


Demographic and Clinical Characteristics of Patients with SLE Across 5 Registries – The LupusNet Federated Data Network

Lupus Nephritis and Response to Treatment in Latin America

The Impact of Active Lupus Nephritis on Work Productivity in Patients From a Latin American Lupus Cohort

Validation of a Score for the Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus: Data from a Latin American Lupus Cohort

Impact of Active Lupus Nephritis on the Quality of Life of Patients From a Latin American Lupus Cohort
Frequency And Associated Factors Of Herpes Zoster Infection In Systemic Lupus Erythematosus Patients From Latin-America

ACR 2026
Orlando, Florida

Anti-C1Q and Anti-DSDNA antibodies centrally assessed predict renal involvement in sle patients from the GLADEL 2.0 cohort.

Intravenous cyclophosphamide versus mycophenolate mofetil for induction therapy in incident lupus nephritis: data from a multi-ethnic, multinational Latin American cohort (GLADEL 2.0)

Pregnancy and obstetric outcomes in systemic lupus erythematosus: insights from the GLADEL 2.0 cohort

Nephritis and its response to therapy using the rail urine biomarkers in the GLADEL cohort
ACR 2026 / Pôsteres colaborativos da LupusNet

Organ Damage and Its Relationship with Disease Activity in Systemic Lupus Erythematosus: Insights from the Lupus Federated Data Network (LupusNet)

Age at Onset and Its Association With Damage Accrual in Systemic Lupus Erythematosus (SLE): Insights From 5 Registries in the Lupus Federated Data Network (LupusNet).

Disease Activity, Organ Damage, and Treatment Exposure in Systemic Lupus Erythematosus With Neuropsychiatric Involvement: Insights From the Lupus Federated Data Network (LupusNet)

Longitudinal Disease Activity, Damage Accrual, and Treatment Exposure in Systemic Lupus Erythematosus With Lupus Nephritis: Insights From the Lupus Federated Data Network (LupusNet)

Systemic Treatment Patterns in Systemic Lupus Erythematosus (SLE): Associations with Disease Severity and Organ-Specific Activity Across 5 Registries in the Lupus Federated Data Network (LupusNet)
PANLAR 2026
Panamá, PANAMÁ

Feasibility of extrarenal Systemic Lupus Erythematosus disease modification in GLADEL 2.0, a Latin American cohort

Incidence of venous thromboembolism, risks factors and impact on quality of life in patients with Systemic Lupus Erythematosus from a Latin American cohort

Intravenous cyclophosphamide versus mycophenolate mofetil for induction therapy in incident lupus nephritis: data from a multi¬ethnic, Multinational Latin American Cohort (GLADEL 2.0)

Systemic Lupus Erythematosus and statins in GLADEL 2.0: are cardiovascular risk prevention guidelines being followed?
15th European Lupus Meeting 2026
Lisboa, PORTUGAL

Systemic Lupus Erythematosus and statins in GLADEL 2.0: are cardiovascular risk prevention guidelines being followed?

Cluster analysis of socioeconomic and environmental determinants modifying activity, chronicity and clinical manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 cohort

Risk factors for pulmonary manifestations in GLADEL 2.0, a Systemic Lupus Erythematosus Latin American cohort
ACR 2025
Chicago, USA

Risk factors for pulmonary manifestations in GLADEL 2.0, a Systemic Lupus Erythematosus Latin American cohort

Effect of gender and follow-up time in damage accrual: Data from a Latin America lupus cohort

Cluster analysis of socioeconomic and environmental determinants Modifying activity, chronicity and clinical manifestations of Systemic Lupus Erythematosus in the GLADEL 2.0 cohort

Feasibility of extrarenal Systemic Lupus Erythematosus disease modification in GLADEL 2.0, a Latin American cohort

Systemic Lupus Erythematosus and statins in GLADEL 2.0: Are cardiovascular risk prevention guidelines being followed?

The renal activity index for lupus identifies and predicts complete renal remission or absence of kidney involvement in Systemic Lupus Erythematosus
EULAR 2025
Barcelona, España

The Renal Activity Index for Lupus Identifies and Predicts Complete Renal Remission or Absence of Kidney Involvement in Systemic Lupus Erythematosus.

Cross cultural validation of Work Productivity and Activity Impairment questionnaire in lupus patients from Latin America.

Effect of gender and follow-up time in damage accrual: data from a Latin America lupus cohort.
16th International Congress on SLE 2025
Toronto, Canada

Delay in diagnosis and treatment of patients with Systemic lupus erythematosus in latin america. A mixed methods study.
%20-%20eposter.jpg)
Living with systemic lupus erythematosus in 2024: latin american experience based on a patient survey.

Systematic review and network meta¬analysis of induction treatments for lupus nephritis

Validation of a score for the prediction of serious Infection in patients with systemic lupus erythematosus: Data from a latin american lupus cohort.
PANLAR 2025
CDMX, Mexico

Delay in diagnosis and treatment of patients with systemic lupus erythematosus in Latin America. A mixed methods study.

Frequency and associated factors of herpes zoster infection in systemic lupus erythematosus patients from Latin America.

Living with systemic lupus erythematosus in 2024: Latin American experience based on a patient survey.

Validation of a score for the prediction of serious infection in patients with systemic lupus erythematosus: Data from a Latin American lupus cohort.

Systematic review and network meta analysis of initial treatments for lupus nephritis.

Socioeconomic and environmental factors associated with clinical manifestations, activity, and chronicity of systemic lupus erythematosus: A multilevel study of the GLADEL cohort.

Delayed diagnosis in Systemic lupus erythematosus.
ACR 2024
Washington, D.C.


Delayed Diagnosis in Systemic Lupus Erythematosus


Demographic and Clinical Characteristics of Patients with SLE Across 5 Registries – The LupusNet Federated Data Network

Lupus Nephritis and Response to Treatment in Latin America

The Impact of Active Lupus Nephritis on Work Productivity in Patients From a Latin American Lupus Cohort

Validation of a Score for the Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus: Data from a Latin American Lupus Cohort

Impact of Active Lupus Nephritis on the Quality of Life of Patients From a Latin American Lupus Cohort
Frequency And Associated Factors Of Herpes Zoster Infection In Systemic Lupus Erythematosus Patients From Latin-America
